Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan

LONDON, August 24, 2010 – While the penetration of picture archiving and communication systems
(PACS) in European hospitals is 80 per cent, the modern radiology information
system (RIS) that drives PACS has only reached a penetration level of about
41 per cent. Legacy RIS modules ubiquitously dominate the market and many
hospitals are reluctant to install a new [...]

Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors

Rubinfeld expected to assist with FDA approval process for autologous cultured skin substitute, PermaDerm(TM)

NEW YORK, August 24, 2010 – Regenicin, Inc. (www.regenicin.com) (OTC Bulletin Board: WDSTD), a
clinical-stage biotechnology company, announced today that Dr. Joseph
Rubinfeld, one of the four original founders of Amgen, Inc.
(www.amgen.com), has agreed to join the company's board of directors.
Dr. Rubinfeld will [...]

CAS Chemistry Research Report: A Decade Later Human Genome Discoveries Spur Growth of Cancer Treatments

COLUMBUS, Ohio, August 24, 2010 – Today, leukemia patients who have struggled with cancer therapy
resistance and intolerance will now have more options thanks to targeted drug
therapy. Such new treatment options are due, in part, to a rapid increase in
journal and patent publications following the discovery of Gleevec, as
reported by Chemical Abstracts Service (CAS), the [...]

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives

BEIJING, August 24, 2010 – Cellonis Biotechnologies, a Beijing and HK-based medical research and
application company, has recorded some remarkable results in the treatment of
a twelve-year-old boy with diabetes using their stem cell therapy in a
Beijing partner hospital. He has completely regained his normal life,
enjoying sports and school activities just like every other person his [...]

Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China

EDMONTON, Alberta, August 24, 2010 – Isotechnika Pharma Inc. ("Isotechnika") (TSX: ISA), a biopharmaceutical
company focused on the discovery and development of immune modulating
therapeutics, and 3SBio Inc. ("3SBio") (NASDAQ: SSRX), a leading China-based
biotechnology company focused on researching, developing, manufacturing and
marketing biopharmaceutical products, today announced the signing of a
development and commercialization agreement for voclosporin, a [...]

Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science

AMSTERDAM, August 30, 2010 -

– Integrates ScienceDirect, Scopus and Targeted Web Content;
Offers New Search and Discovery Applications -

– Opening APIs to Encourage Development of Customized Solutions -

Elsevier, (www.elsevier.com/) a world-leading publisher of
scientific, technical and medical information [...]

Late-Breaking Analysis in Hypertension Shows That Antihypertensive Treatments Differ in Their Ability to Preserve Lives

STOCKHOLM, August 30, 2010 – According to the results of a late-breaking analysis involving more than
200 000 patients who participated in recent clinical trials, antihypertensive
treatments with renin-angiotensin system (RAS) inhibitors significantly
differ in their ability to preserve lives.(1) This new analysis, presented
today at the European Society of Cardiology (ESC) Congress, revealed that
patients receiving a treatment [...]

Video : ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed with Urgent Angioplasty

Composite Primary Endpoint: Risk Reduction of 17% (Non-Statistically Significant ) in Death, Complication of Myocardial Infraction, Procedure Failure or Major Bleeding (p=0.07)

PARIS, August 30, 2010 – The international ATOLL study sponsored by the Assistance Publique -
Hopitaux de Paris showed that enoxaparin reduced the composite of death,
complication of myocardial infraction, procedure failure or major bleeding [...]

New International Survey Shows Pharmacists Key to Improving Patients’ Health

LISBON, Portugal, August 30, 2010 – A new international survey shows that over 90% of pharmacists believe
they are key to improving patients' health, and while most pharmacists
surveyed see their responsibilities increasing, they voice concerns on
training and pay. The survey shows that almost 3 in 4 pharmacists (73%) now
provide patients with health promotion and management [...]

Philips Introduces Newly Enhanced Cardiac Ultrasound System

iE33 xMATRIX system offers expanded clinical applications in cardiac ultrasound imaging

STOCKHOLM, August 30, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the
enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic
solution for more efficient adult echocardiograms, the X5-1 transducer. With
this enhanced technology, Philips continues its tradition of simplified,
patient-focused healthcare solutions by [...]

Nationwide Prostate Screenings to Detect Cancer and Help Save Lives

Prostate Conditions Education Council Hosts Awareness Week, September 19-25
DENVER, August 30, 2010 – A council of leading prostate cancer experts is working to protect the
lives of American men by providing lifesaving prostate cancer screenings. The
Prostate Conditions Education Council (PCEC) – a national organization
committed to men's health and a leader in prostate cancer screening – [...]

InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative

The Stent for Life Initiative (SFL) Celebrates its First Year Anniversary as the ESC 2010 Congress in Stockholm, Monday August 30th

STOCKHOLM, August 30, 2010 – InspireMD Ltd., a medical device company engaged in the development and
commercialization of MGuard(TM) novel stent systems, is happy to announce
that it has joined the Stent for Life Initiative as [...]

Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial

Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders

LEUVEN, Belgium, September 1, 2010 – ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on the discovery and development of innovative treatments for
eye disease, vascular disease and cancer announces that its second Phase III
trial evaluating microplasmin [...]

Amsterdam Molecular Therapeutics Reports Half-Year Results 2010

AMSTERDAM, The Netherlands, August 31, 2010 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field
of human gene therapy, today reported its results for the first half year of
2010.

Highlights

– Glybera(R):
– EMA initiated MAA review in 01/2010
– Approval [...]

InSightec Treats First Prostate Cancer Patients in Clinical Trials

ExAblate(R) MR Guided Focused Ultrasound System is Being Used for the First Time for Non-invasive Treatment of Prostate Cancer

TIRAT CARMEL, Israel, August 31, 2010 – InSightec Ltd., the global leader in MR guided focused ultrasound
technology and the only company to receive FDA approval for its ExAblate(R)
system for treating uterine fibroids, announced today that its [...]

PharmaVentures Appoints Paul Phull as Senior Director

New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

OXFORD, England, August 31, 2010 – PharmaVentures Ltd (www.pharmaventures.com) ("PharmaVentures")
today announced that Paul Phull has joined the company as Senior Director.
With more than 24 years of senior level commercial, business/corporate
development and [...]

Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)

A New Tool is Targeted to Specialists in PKU, Offering an Advanced Educational Pathway Consisting of CME Accredited e-Learning Modules

ROME, August 31, 2010 – PKU specialists around the world can now count on a brand-new,
authoritative website entirely dedicated to this rare genetic disorder, which
affects one out of every 10,000 to 20,000 live births worldwide.

[...]

Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products

LONDON, August 31, 2010 – Following a recent analysis of the medical imaging devices market, Frost
& Sullivan presented Lodox Systems (Pty) Ltd (Lodox) with the "2010 South
African Medical Imaging Product Quality Leadership Award". Statscan, Lodox's
digital x-ray product, stunned the market with its ability to produce clear,
diagnostic, whole-body x-ray pictures in just 13 seconds.

[...]

ASP GLOSAIR(TM) Decontamination Technology Undertakes Deep Clean at Royal Liverpool Hospital to Promote Better Patient Care

LONDON, August 31, 2010 – Advanced Sterilization Products (ASP) announced today a partnership with
the Royal Liverpool University Hospital to strengthen their infection
prevention efforts and promote better patient care by utilizing ASP's proven
GLOSAIR(TM) area decontamination technology.

As part of a larger refurbishment project, Royal Liverpool University
Hospital has appointed ASP to perform their [...]

OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces

HOUSTON, August 31, 2010 – OrthoAccel Technologies, Inc. (www.acceledent.co.uk/home)
announced this week that following a successful limited market release of
AcceleDent last October it will be initiating a full-market release
throughout the United Kingdom this coming September. Availability of
AcceleDent (www.acceledent.co.uk), which is a regulated medical device
and only available to dental professionals to prescribe to their patients,
will be [...]

New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets

DALLAS, August 31, 2010 – More than 10,00,000 new cases of skin nonmelanoma cancer has been
reported for the current year only in U.S. This enhanced the market for anti
skin cancer drugs and therapies within the dermatology market. Dermatology
continues to remain one of the promising sectors within the pharmaceutical
market due to recent drug developments in [...]

CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up

The Publication of 10-Year Follow-Up Test Results on the First CYPHER(R) Sirolimus-Eluting Coronary Stent Patient Reveal the Stent's Outstanding Efficacy and Safety

STOCKHOLM, August 31, 2010 – Cordis Corporation, a worldwide leader in the development and manufacture
of interventional vascular technology, announced today at European Society of
Cardiology in Stockholm that the results of follow-up tests undertaken [...]

Glenmark Announces the Discovery of a Novel Chemical Entity ‘GRC 17536′, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally

With This Announcement, Glenmark has Clearly Reaffirmed its Position Globally as the Leader in the TRP Space

MUMBAI, India, August 31, 2010 – Glenmark Pharmaceuticals today announced the discovery of a
Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting
TRPA1 receptor antagonists for pain and respiratory disorders. TRPA1 belongs
to Transient Receptor Potential (TRP) family [...]

Henry Schein Provides Health Care Products for Relief After Flooding in Pakistan

Company establishes matching relief fund for Pakistan through Henry Schein Cares Foundation

MELVILLE, New York, August 31, 2010 – Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care
products and services to office-based practitioners, is working with its non-
governmental organization (NGO) partners – Direct Relief, International
Medical Corps, Americares, and Heart to Heart – to [...]

The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports

DALLAS, Texas, August 31, 2010 – ReportsandReports announces it will carry the The Top 10 Cardiovascular
Device Companies: Market trends, growth strategies, and SWOT analyses Market
Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/the-top-10-cardiovascular-dev
ice-companies-market-trends-growth/
Search More Then 45000 Market Research Reports at ReportsandReports
(www.reportsandreports.com/)
The cardiovascular [...]

ScinoPharm to Invest in Tanvex Biologics

TAINAN, Taiwan, August 31, 2010 – ScinoPharm, a leading active pharmaceutical ingredient (API) developer
and manufacturer headquartered in Taiwan, today announced an investment into
Tanvex Biologics, Inc., a United States company registered in the State of
Delaware. ScinoPharm's investment was in the form of tangible assets,
intellectual properties, as well as cash.

Tanvex specializes in [...]

Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients

Study meets primary endpoint of reducing lactate levels in trauma patients treated with MP4OX

SAN DIEGO, August 31, 2010 – Sangart, Inc., today announced positive results from its Phase IIa
proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely
injured trauma patients with hemorrhagic shock causing lactic acidosis. The
study demonstrated that MP4OX, when given in addition to [...]

New Data Supports Valdoxan’s(R) Unique Clinical Signature

AMSTERDAM, August 31, 2010 – Valdoxan(R)/Thymanax(R) (agomelatine) is more efficacious than
both conventional selective serotonin reuptake inhibitor (SSRI) and serotonin
noradrenaline reuptake inhibitor (SNRI) antidepressants, according to new
data presented today at the 23rd European College of Neuropsychopharmacology
(ECNP) Congress.

To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/valdoxan/44196/
[...]

Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients

First Results From the TEMSO Phase III Trial to be Presented During the ECTRIMS Congress in October 2010

PARIS, August 30, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today
that the investigational once-daily oral drug teriflunomide significantly
reduced annualized relapse rate (ARR) at 2 years versus placebo in patients
with relapsing multiple sclerosis (RMS), thus achieving [...]

ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed with Urgent Angioplasty

Composite Primary Endpoint: Risk Reduction of 17% (Non-Statistically Significant ) in Death, Complication of Myocardial Infraction, Procedure Failure or Major Bleeding (p=0.07)

PARIS, August 30, 2010 – Pitie-Salpetriere Hospital, Paris, France, August 30th 2010.
The international ATOLL study sponsored by the Assistance Publique – Hopitaux
de Paris showed that enoxaparin reduced the composite of death, complication
of myocardial [...]

From the Laboratory to the Reality of Daily Life

Picture is available via epa european pressphoto agency and can be downloaded free of charge at: https://www.presseportal.de/pm/32079

DUDERSTADT, Germany, August 30, 2010 – Christian Kandlbauer, who lost both of his arms in a high
voltage accident, uses a unique development which until recently sounded
almost like science fiction: An arm prosthesis, the first of its kind in [...]

Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science

AMSTERDAM, August 30, 2010 -

– Integrates ScienceDirect, Scopus and Targeted Web Content;
Offers New Search and Discovery Applications -

– Opening APIs to Encourage Development of Customized Solutions -

Elsevier, (www.elsevier.com/) a world-leading publisher of
scientific, technical and medical information [...]

DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System – Orcatherm(TM)

YORK, England, September 1, 2010 – Formerly DGP Group, Intelsius, a global manufacturer and distributor of
environmentally safe, temperature-controlled and regulatory-compliant
packaging solutions, announced the completion of its corporate rebranding
efforts, including a new corporate identity, logo and redesign of its
flagship website.

The rebranding leverages the strong credibility the company has developed
over the past [...]

Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & Sullivan

LONDON, September 1, 2010 – The pharmacy automation systems market in Europe is experiencing a
tremendous growth spurt. Until recently, most pharmacies have been either
without automation or have employed very basic automation systems. In
response, the adoption rate of automation systems across Europe has been
progressing from basic prescription management systems to advanced medication
pick-up and drug dispensing [...]

Helsinn Announces the Official Opening of its New R&D Centre of Excellence in Dublin

The Minister for Finance, Mr. Brian Lenihan T.D. Today Performed the Official Opening of the Centre Which Will Play a Significant Role in Helsinn Group's Pipeline of New Products

LUGANO, Switzerland, September 1, 2010 – The Swiss pharmaceutical group Helsinn announced the official opening,
performed today by the Minister for Finance, Mr. Brian Lenihan T.D, of [...]

CPM Resource Center’s 19th International Conference to Focus on Sustainable Healthcare Transformation

Annual Conference to be Held Jan. 19-22, 2011, and Focus on Transforming Healthcare Through Evidence-Based Clinical Content, Partnerships and Technology

GRAND RAPIDS, Michigan, September 1, 2010 – CPM Resource Center (CPMRC) (www.cpmrc.com), an Elsevier company
and leader in assisting healthcare organizations improve practice at the
point of care, today announced that its 19th International Conference
(www.cpmrc.com/consortium/conference) will take [...]

Novasep Appoints a New Chairman for its Supervisory Board

Bernard Dubois, Former Aventis Senior VP of Global Industrial Operations Brings a Wealth of Experience to Novasep's Top Management Team

POMPEY, France, September 1, 2010 – Novasep, a leading supplier of manufacturing solutions to the life
science industries, announces the appointment of Bernard Dubois as Chairman of
its supervisory board. Bernard Dubois replaces Pietro Stefanutti, who decided
to [...]

Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain

READING, England, September 1, 2010 – Archimedes Pharma Ltd., a leading international specialty
pharma company, today announced that the European Commission has granted
marketing authorisation for its lead product, PecFent*, an innovative
fentanyl nasal spray for the treatment of breakthrough cancer pain (BTCP) in
adults who are already receiving maintenance opioid therapy for chronic
cancer pain.

[...]

US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls

GENEVA, September 1, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
announced today that MS LifeLines, a US educational and support service which
includes a call center, has achieved a milestone in servicing one million
in-bound calls since its inception in 2002. MS LifeLines is sponsored by EMD
Serono, Inc. an affiliate of Merck KGaA, [...]

Cancer Center to be the First in Europe to Install a CyberKnife VSI System, the Latest Generation of the CyberKnife System

The Leon-Berard Center of Lyon, France, is now offering its cancer patients the benefits of Full Body Radiosurgery

SUNNYVALE, California, September 1, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced that the first CyberKnife VSI System to be
installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary
Center (CLB) [...]

Olivier BOHUON Appointed Chief Executive Officer of Pierre Fabre SA

CASTRES, France, September 1, 2010 – During its first meeting, the Board of Directors of Pierre
Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the
company's Chief Executive Officer.

Olivier BOHUON, 51, has until now been the executive
vice-president of Abbott Corporation and president of its pharmaceutics
division. In this capacity, he [...]

ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells

YOKOHAMA, Japan, September 1, 2010 – ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) is pleased to
announce a new line of products to be launched in the autumn of 2010,
offering neuronal cells derived from human iPS (induced pluripotent stem)
cells.

Since April 2009, ReproCELL has been manufacturing iPS
cell-derived cardiomyocytes for drug toxicity testing as [...]

ITC Global Security Announces Board Changes and Senior Appointments

Reinforcing the Executive Management Team to Facilitate Global Expansion
LONDON, September 1, 2010 – Photograph available (www.itcsecurity.com/about-itc/newsroom-and-events/itc-global-security-board-changes-and-senior-appointments )

ITC Global Security (www.itcsecurity.com/about-itc/newsroom-and-events/itc-global-security-board-changes-and-senior-appointments ),
a specialist information security and advanced networking firm, today
announced a Board restructure and new senior appointments. The new structure
consolidates the strengths of the group to support the future direction and
growth [...]

French Laboratoires Thea Acquires the Mydriasert(R) ophthalmic Insert From Carl Zeiss Meditec

CLERMONT-FERRAND, France, September 1, 2010 – Laboratoires Thea, the leading independent ophthalmic group in
Europe, completes its innovative product range with the announcement of the
final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic
ophthalmic insert, is indicated for dilated fundus examination (DFE) or
cataract surgery, the most widely implemented surgical procedure. Regarding
cataract surgery, the market represents close to [...]

PruHealth Set to Grow Following Approval of Standard Life Healthcare Acquisition

LONDON, September 1, 2010 – PruHealth has become a competitor of scale in the UK Private Medical
Insurance (PMI) market following the completion of the acquisition of
Standard Life Healthcare by Discovery Holdings* of South Africa.

The acquisition opens a new chapter in PruHealth's
development, boosting cover to 700,000 lives and market share to [...]

DM Corporation and ORF Genetics to Collaborate on Protein Drugs

An MOU Signed During Official Visit of Mrs. Preneet Kau, Indian Minister of State for External Affairs, to Iceland

REYKJAVIK, Iceland and KOLHAPUR, India, September 1, 2010 – The Indian company DM Corporation and ORF Genetics of Iceland
are to collaborate on the development, production and marketing of protein
drugs. Mr. Dilip Mohite, Chairman and Managing Director [...]

Colorcon Opens Technical Service Laboratory in Istanbul, Turkey

HARLEYSVILLE, Pennsylvania, September 1, 2010 – Colorcon Limited today announced the opening of a new technical service
laboratory in Turkey. Located in Atasehir, the southern area of Istanbul, the
new laboratory contains fully equipped processing suites for laboratory-scale
immediate and modified release film coating trials. The facilities are
available for customer use, operating under the highest standards of
confidentiality [...]

New England Journal of Medicine Study Shows New Molecular TB Test Could Offer Rapid and Effective Diagnosis in Developing Countries

Fast, accurate and easy-to-use TB test could revolutionize diagnosis of a disease that kills nearly two million people annually

GENEVA, September 1, 2010 – A study(1) published in The New England Journal of Medicine today reports
that a new molecular tuberculosis (TB) test, Xpert(R) MTB/RIF, provides
highly sensitive detection of tuberculosis and drug resistance in low
resource settings [...]

Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports

DALLAS, September 2, 2010 – ReportsandReports announces it will carry the Epigenetics Therapeutics to
2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia,
Multiple Myeloma and Cutaneous T-Cell Lymphoma Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/epigenetics-therapeutics-to-2
017-high-market-potential-for-epig/
Search More Then 45000 Market Research Reports at [...]

MarketsandMarkets New Report – Global Weight Loss and Diet Management Market (2009 – 2014)

DALLAS, Texas, September 2, 2010 – Buy this report now:
www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients-
225.html

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
This market report analyzes the trends prevailing in the
digestive health [...]

iDent Imaging Teams with Objet Geometries to Offer Surgical Guide Solutions For Implant Dentistry

FOSTER CITY, California and REHOVOT, Israel, September 2, 2010 – iDent Imaging Inc., (www.ident-surgical.com/ ) (Foster City, CA) a
leading provider of 3-D surgical planning software and surgical guides for
dental implants, has teamed with Objet Geometries Ltd. (www.objet.com/
) (Rehovot, Israel), innovation leader of 3-Dimensional printing systems, to
improve the quality of dental implant placement. Objet systems [...]

Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups

Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions

STOCKHOLM, September 2, 2010 – Three new analyses of subgroups from the SORT OUT III study
presented at the European Society of Cardiology (ESC) meeting [...]

IBA Sells Prototype of Next Generation Carbon Therapy System

Leader in Proton Therapy Applies Expertise Towards New Technologies in Cancer Treatment

LOUVAIN-LA-NEUVE, Belgium, September 2, 2010 – IBA (Ion Beam Applications S.A.), developer of equipment and
pharmaceuticals dedicated to cancer diagnosis and treatment, announced today
that it has sold the prototype of its next generation carbon therapy system
to the French company CYCLHAD (un CYCLotron pour l'HADronth??rapie, [...]

Manufacturing of Biologics – Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports

DALLAS, Texas, September 2, 2010 – ReportsandReports announces it will carry Manufacturing of Biologics
(www.reportsandreports.com/market-reports/manufacturing-of-biologics-i
ncreasing-demand-for-monoclonal-ant/) – Increasing Demand for Monoclonal
Antibodies and Recombinant Proteins Drives Increases in Capacities and
Innovative Production Technologies Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/manufacturing-of-biologics-in
creasing-demand-for-monoclonal-ant/
Search More Then 45000 Market Research Reports at [...]